Status:
COMPLETED
The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae
Lead Sponsor:
National University of Malaysia
Conditions:
Labor Long
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This study compares the duration of active phase of labour in women who received buscopan and those who don't.
Detailed Description
A randomised control study involving primigravida in labour who require pitocin augmentation. Once patient require augmentation, patient will be randomised into intervention group (receiving intraveno...
Eligibility Criteria
Inclusion
- Primigravida
- Vertex presentation
- Term gestation (37-41w)
- Active phase of labor (4cm with regular contraction at least 2:10)
- Spontaneous labor
- Oxytocin augmentation
- Maternal height ≥150cm
Exclusion
- Multiple pregnancies
- Previous uterine surgery
- Hypertensive disease in pregnancy
- Gestational diabetes on treatment
- Clinical estimation of fetal weight \>3.8kg
- Induction of labor
- Meconium stained liquor
- Allergy to hyoscine
- Medical contraindication to hyoscine (i.e Myasthenia gravis, glaucoma, megacolon)
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04349722
Start Date
December 1 2019
End Date
June 30 2020
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Malaysia Medical Centre
Cheras, Kuala Lumpur, Malaysia, 56000